二维剪切波弹性成像排除显著纤维化的界值:系统综述、荟萃分析与外部验证
汇总受试者工作特征曲线下面积为0.84(95%CI 0.81-0.87),排除界值6.6 kPa(95%CI 5.4-8.2 kPa)的灵敏度为80.0%、特异度为70.7%,外部验证(N=163)显示灵敏度0.86、特异度0.68。
要点
- 二维剪切波弹性成像诊断MAFLD显著纤维化的汇总AUC为0.84。
- 6.6 kPa作为排除界值,灵敏度80.0%、特异度70.7%。
- 在5%和10%患病率下,该界值阴性预测值超过95%。
核心结论
- 二维剪切波弹性成像对MAFLD显著纤维化具有良好的诊断准确性,肝硬度6.6 kPa可可靠排除显著纤维化。
主要发现
- 汇总AUC为0.84(95%CI 0.81-0.87),汇总灵敏度79.6%、特异度76.0%。
- 排除界值6.6 kPa(95%CI 5.4-8.2 kPa)的灵敏度为80.0%、特异度为70.7%。
- 在5%和10%患病率下,该界值阴性预测值超过95%。
- 诊断性能在各亚组中总体保持,但在代谢负担较重人群和使用Supersonic超声平台的研究中略有减弱。
- 外部验证(N=163)显示灵敏度0.86、特异度0.68,与荟萃分析结果一致。
关键数值与推荐
- 排除界值定义为汇总灵敏度≥80%的最高阈值,最终确定为6.6 kPa(95%CI 5.4-8.2 kPa)。
- 该界值下汇总灵敏度80.0%、特异度70.7%,汇总AUC 0.84(95%CI 0.81-0.87)。
临床怎么用
- 二维剪切波弹性成像可整合于常规超声系统,肝硬度6.6 kPa可用于排除MAFLD患者的显著纤维化,有助于在专科中心以外推广纤维化筛查。
局限性
- 诊断性能在代谢负担较重人群和使用Supersonic超声平台的研究中略有减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Two-dimensional shear-wave elastography is a practical method for assessing liver fibrosis. However, an optimal cutoff value to rule out significant fibrosis (≥F2) in metabolic dysfunction-associated steatotic liver disease remains unclear. This study aimed to determine the evidence-based rule-out cutoff through diagnostic meta-analysis. METHODS: A systematic review was of MEDLINE, EMBASE, and Cochrane CENTRAL was performed through December 2025 for studies evaluating 2-dimensional shear-wave elastography with liver biopsy as the reference standard. Pooled sensitivity, specificity, and summary area under the receiver operating characteristic curve were estimated. The rule-out cutoff was defined as the highest threshold achieving pooled sensitivity ≥80%. External validation was performed using an independent clinical cohort. RESULTS: Twenty-two studies involving 3171 adults with biopsy-proven metabolic dysfunction-associated steatotic liver disease were analyzed. The summary area under the receiver operating characteristic curve was 0.84 (95% confidence interval, 0.81-0.87), with pooled sensitivity of 79.6% and specificity of 76.0%. The rule-out cutoff of 6.6 kPa (95% confidence interval, 5.4-8.2 kPa) achieved sensitivity of 80.0% and specificity of 70.7%. At this threshold, negative predictive value exceeded 95% at prevalences of 5% and 10%. Diagnostic performance was generally preserved across subgroups but was modestly attenuated in populations with greater metabolic burden and in studies using Supersonic ultrasound platforms. External validation (N = 163) demonstrated consistent sensitivity (0.86) and specificity (0.68). CONCLUSIONS: Two-dimensional shear-wave elastography demonstrated good diagnostic accuracy for significant fibrosis in metabolic dysfunction-associated steatotic liver disease. A liver stiffness of 6.6 kPa can reliably rule out significant fibrosis. As 2-dimensional shear-wave elastography can be integrated into conventional ultrasound systems, it may facilitate broader implementation of fibrosis screening beyond specialized centers. CLINICAL TRIAL NUMBER: PROSPERO (International Prospective Register of Systematic Reviews), CRD42024616042.
引用
- Oh JH, Lee J, Choi M, et al. Rule-Out Cutoff of Two-Dimensional Shear Wave Elastography for Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Systematic Review, Meta-Analysis, and External Validation. Clin Gastroenterol Hepatol. 2026. PMID: 42235867. doi:10.1016/j.cgh.2026.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。